Obitazidine fumarate
富马酸奥比特嗪
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameObitazidine fumarate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[10]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Zhenxing Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShenzhen Zhenxing Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active Indications +[10]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A